Oxford Nanopore Hereditary Cancer Panel

About Oxford Nanopore

Oxford Nanopore Technologies (ONT) is a pioneer in nanopore-based sequencing, offering a disruptive technology that reads native DNA and RNA strands in real-time with ultra-long read capabilities. Its platform is distinguished by its portability, scalability from palm-sized to benchtop devices, and ability to deliver multiomic data, including direct epigenetic detection. As a publicly traded company, ONT has moved beyond early revenue into a revenue-generating commercial stage, targeting a broad range of research, applied, and future diagnostic markets globally.

Other Hereditary cancer risk Drugs